Clinical Trials Logo

Solar Lentigo clinical trials

View clinical trials related to Solar Lentigo.

Filter by:
  • Active, not recruiting  
  • Page 1

NCT ID: NCT06288607 Active, not recruiting - Solar Lentigo Clinical Trials

Safety and Efficacy of High Intensity Focused Ultrasound in Solar Lentigo: A Self-controlled Study

Start date: November 16, 2023
Phase:
Study type: Observational

This trial is a single-center, prospective self-controlled study. The study proposes to recruit 30 patients with solar lentigo on both sides of the face. Patients are randomly assigned to be treated with high-intensity focused ultrasound (MFUS One, Hunan Peninsula Medical Technology Co., Ltd., China) on one side, and the other side is not treated. The Lab* values of the lesion area and the area around the lesion are detected separately using 3nh HIGH-QUALITY COLORMETER colorimeter (Konica-Minolta Company, Japan), and skin lesion images are collected with dermatoscope and VISIA® (Canfield Company, USA). Measurements of Lab* values and related images at the same location, along with adverse events, physician and subjective global aesthetic improvement scale scores are recorded before and at week2, week 4, week6. At the end of the follow-up on the treatment side, the same parameter treatment is provided for the untreated side, and the corresponding observation items are recorded for the patient before treatment, and at week2, week4, and week6 respectively.